Novo Nordisk backs up M&A pledge by appointing deal-minded board chair
admin 23rd March 2018 Uncategorised 0Just weeks after Novo Nordisk lost out to Sanofi in a race to buy the pipeline-boosting biotech Ablynx, the Danish drugmaker is far from out of the M&A game. For its new board chairman, Novo chose Helge Lund, an oil-industry veteran with plenty of deals under his belt.
More: Novo Nordisk backs up M&A pledge by appointing deal-minded board chair
Source: fierce